The end of October in Frankfurt always feels special.
From October 28 to 30, CPHI Europe 2025 took place here. This is an event where the pharmaceutical industry gathers not to make loud statements, but to discuss what is happening in the market and where it is heading.
CPHI has long ceased to be just an exhibition. Over more than thirty years, it has become a space where partnerships are formed, ideas are born, and the future of the industry gradually takes shape. Here, equal attention is paid to scientific developments, production processes, and the dietary supplements segment, which has been developing particularly dynamically in recent years.
For Vorwarts Pharma, participation in CPHI Europe 2025 was a logical continuation of its systematic international work. Over three days, the company’s team held more than twenty meetings with partners from Europe, Asia, and the Middle East. The focus of the discussions was on product development, strategic expansion, and new projects in the field of dietary supplements.
Interestingly, there was a lot of talk about artificial intelligence at CPHI this year. It is already being actively used not only in research, but also for forecasting demand and optimizing supply chains. Another trend that was evident everywhere was the growing attention to the environmental friendliness of packaging and the transparency of product composition.
It is interesting to note that artificial intelligence was a hot topic at CPHI this year. It is already being actively used not only in research, but also for forecasting demand and optimizing supply chains. Another trend that was evident everywhere was the growing focus on environmentally friendly packaging and transparency in product composition.
Vorwarts Pharma’s preparations for the exhibition did not begin suddenly and were not limited to a single schedule. Over several months, the team gradually gathered information about the market, selected potential partners, and refined the topics of discussion and goals for each meeting. It was not the number of contacts that was important, but their significance.
That is why participation in CPHI was not a mere formality. The trip gave a clear sense of the direction in which to move forward, an understanding of what is important to work on now, and which decisions no longer make sense to postpone.
It is important for the company not only to talk about its own achievements. It is equally valuable to hear how partners think, what challenges they face, and what consumers in different countries expect. Often, such conversations are much more valuable than any reports.
Vorwarts Pharma continues to strengthen its position in the global market, maintaining its focus on product quality and the human dimension of cooperation. CPHI Europe 2025 was further confirmation that sustainable development is built on trust, professionalism, and the ability to listen to each other.
